Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome

被引:0
作者
Yangfan Hou
Lei Dong
Xiaolan Lu
Haitao Shi
Bing Xu
Wenting Zhong
Lin Ma
Shuhui Wang
Caifeng Yang
Xinyi He
Yidi Zhao
Shenhao Wang
机构
[1] Xi’an Jiaotong University Second Affiliated Hospital,Department of Gastroenterology
[2] Xi’an Jiaotong University Second Affiliated Hospital,Pulmonary and Critical Care Medicine
[3] Shanghai Pudong Hospital,Department of Gastroenterology
[4] Xi’an Jiaotong University Medical College First Affiliated Hospital,International Medical Ward
[5] Xi’an City First Hospital,Departments of Gastroenterology
[6] Xi’an Jiaotong University Second Affiliated Hospital,Emergency Department
来源
Digestive Diseases and Sciences | 2022年 / 67卷
关键词
Fecal microbiota; Intestinal mucosal microbiota; Irritable bowel syndrome; Clinical manifestations;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:5580 / 5592
页数:12
相关论文
共 216 条
[11]  
Jones MP(2014)Neuroplasticity and dysfunction after gastrointestinal inflammation Nat Rev Gastroenterol Hepatolb 11 611-627
[12]  
Tack J(2017)Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis Dig Liver Dis 49 331-337
[13]  
Oudenhove LV(2018)Female-specific association between variants chromosome 9 and self-reported diagnosis of irritable bowel syndrome Gastroenterology. 155 168-179
[14]  
Pohl D(2016)Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV Gastroenterology 150 1262-1279
[15]  
Van Oudenhove L(2019)The microbiota-gut-brain axis Physiol Rev 99 1877-2013
[16]  
Törnblom H(2002)Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome Dig Liver Dis 34 48-53
[17]  
Le Nevé B(2014)A role for the gut microbiota in IBS Nat Rev Gastroenterol Hepatol 11 497-505
[18]  
Tack J(2016)Diet-microbiota interactions as moderators of human metabolism Nature 535 56-64
[19]  
Simrén M(2018)Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial Lancet Gastroenterol Hepatol 3 17-24
[20]  
Everhart JE(2017)The mucosal immune system: master regulator of bidirectional gut-brain communications Nat Rev Gastroenterol Hepatol 14 143-159